Current Advances on Neurodegeneration: from Molecular biology to Translational Medicine
Understanding the cellular and molecular mechanisms underlying diseases such as Alzheimer, Parkinson, Lateral Amyotrophic Sclerosis, Inborn Errors of Metabolism, Neuromuscular Diseases, among others, affecting individuals and populations of different ages around the world, is crucial for developing early diagnostic tools and therapeutic agents/strategies. Current research on neurodegenerative diseases is an interdisciplinary field that combines clinical sciences, classical Neuroscience and Cell Biology with other disciplines (i.e. molecular biology, biophysics, etc.), as well as novel, innovative and advanced techniques (stem cell research, bioinformatics, imaging, etc.), to generate breaking discoveries. It is therefore essential to keep in pace with this fast moving and exciting research area. The 2017 Current Advances on Neurodegeneration: from Molecular Biology to Traslational Medicine AvH Kolleg in Córdoba (Argentina) will cover several topics of this fast growing field with deep social impact, in times where the expectation of life length increases due to advances on Translational Medicine all over the World.
The 2017 Current Advances on Neurodegeneration: from Molecular Biology to Traslational Medicine AvH Kolleg arises from the concept that scientists working on similar problems should meet regularly. This occurs very frequently in the United States, Europe, and some countries in Asia, like Japan and more recently China. The situation is quite different in South America. With the exception of large Society meetings (e.g. Annual Meeting Argentine Society of Biochemistry, Chilean Society of Cell Biology) that attract the attention of many scientists, more focused and smaller events such as, workshops, symposia or international courses/conferences on timely topics are rare events and/or difficult to attend, especially for graduate and postgraduate students. This situation also affects young or established scientists since it implies limited opportunities for presenting their work to a highly qualified international audience, or to learn about recent advances, trend topics, new state-of-the-art technologies, etc., as well as to foster and establish fruitful and long term collaborations. All these considerations highlight the importance of organizing small focused scientific meetings on cutting-edge topics with international recognized experts.